Warren R, Blauvelt A, Bagel J, Papp K, Yamauchi P, Armstrong A, Langley R, Vanvoorden V, De Cuyper D, Peterson L, Cross N, Reich K. Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). J of Skin [Internet]. 2021Jan.1 [cited 2024May1];5(1):s15. Available from: https://jofskin.org/index.php/skin/article/view/1168